Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Barrier Therapeutics Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Barrier Therapeutics Inc since year 2005.
Table 2 shows the detailed insider transactions of Barrier Therapeutics Inc since 2005.
The reporting company's ticker symbol is BTRX. The reporting company's CIK number is 1173657.
The total value of stock buying since 2005 is $146,581,383.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-08-06||Stiefel Charles W (Other)||Buy||1,033,464||4.15||4,288,875|
|2008-08-05||Stiefel Charles W (Other)||Buy||34,266,494||4.15||142,205,950|
|2006-11-13||Erickson Edward L (Director)||Buy||2,000||7.24||14,470|
|2006-09-27||Jacey Charles F Jr (Director)||Buy||300||6.40||1,920|
|2006-08-09||Cauwenbergh Geert (Chief Executive Officer)||Buy||2,000||5.43||10,862|
|2006-05-19||Cauwenbergh Geert (Chief Executive Officer)||Buy||5,000||6.17||30,840|
|2006-03-15||Cauwenbergh Geert (Chief Executive Officer)||Buy||2,000||9.25||18,496|
|2006-03-06||Campbell Robert E (Director)||Buy||1,000||9.97||9,970|
Insider trading activities including stock purchases, stock sales, and option exercises of BTRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Barrier Therapeutics Inc (symbol BTRX, CIK number 1173657) see the Securities and Exchange Commission (SEC) website.